0001209191-20-032004.txt : 20200526
0001209191-20-032004.hdr.sgml : 20200526
20200526162029
ACCESSION NUMBER: 0001209191-20-032004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200521
FILED AS OF DATE: 20200526
DATE AS OF CHANGE: 20200526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lacey David L.
CENTRAL INDEX KEY: 0001734422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 20910801
MAIL ADDRESS:
STREET 1: 3280 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-21
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001734422
Lacey David L.
C/O 3928 POINT EDEN WAY
HAYWARD
CA
94545
1
0
0
0
Stock Option (right to buy)
36.34
2020-05-21
4
A
0
50000
0.00
A
2030-05-20
Common Stock
50000
50000
D
The option is exercisable in 36 equal monthly installments after May 21, 2020, subject to the Reporting Person's continued service to the Company.
/s/ Carolyn Tang, Attorney-in-Fact
2020-05-26